Placement Announced
Neurizon Therapeutics placement
A$4.3m raised
Announced 2 Nov 2026 · ASX: NUZ · A$0.068 cash per share
Advisers
Neurizon Therapeutics
Issuer
Not disclosed
Lead managers
- Joint lead manager
- Bookrunner
- Issuer
- Neurizon Therapeutics
- Sector
- Biotech and pharmaceuticals
Similar deals
- Chimeric Therapeutics placement Dec 2025 · A$4.4m · Biotech and pharmaceuticals
- TrivarX placement Oct 2025 · A$4.2m · Biotech and pharmaceuticals
- Recce Pharmaceuticals placement Jun 2026 · A$4m · Biotech and pharmaceuticals
- NeuroScientific Biopharmaceuticals placement Apr 2025 · A$3.5m · Biotech and pharmaceuticals
- Tryptamine Therapeutics placement Nov 2025 · A$6.1m · Biotech and pharmaceuticals
Sources
- 2 Nov 2026 Firm commitments to raise A$4.3m and announcement of SPP ASX